spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  cortisol 

 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution
 HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 17 Jul 2018
Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 4 Dec 2017
Spruce Biosciences Receives FDA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2017
Spruce Biosciences Provides Corporate Update on Series A Venture Financing, Leadership Team and Lead Clinical Program
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 May 2015
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Biopharmaceuticals Acquisitions Licensing Venture Capital
 HSMN NewsFeed - 9 Oct 2014
Cortendo Appoints Robert Lutz as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2014
Cortendo AB: First Patient Enrolled into NormoCort Phase 3 SONICS Trial Following a Successful EU Investigator Meeting
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2014
Cortendo Appoints Matthew Pauls as Chief Executive Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 Oct 2012
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
FDA Accepts Submission of New Drug Application for CORLUX for Cushing's Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Dec 2010
Corcept Therapeutics Announces Positive Phase 3 Study Results for CORLUX for the Treatment of Cushing's Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2008
Caroline Loewy Joins Corcept as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Orexo Shows Positive Results in Completed Comparative Phase III Profile Study of the Sublinox(TM) Sleep Aid Involving Insomnia Patients
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2007
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Sep 2007
Corcept Therapeutics Receives FDA Notification Opening IND for CORLUX(R) for the Treatment of Cushing's Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 9 Jul 2007
Corcept Therapeutics Receives Orphan Drug Designation for CORLUX(R) Treatment of Cushing's Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2007
DiObex Announces the Appointment of David Cory as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2007
Corcept Therapeutics Announces $9 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Mar 2007
Corcept Therapeutics Announces Chief Financial Officer Resignation
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2007
Corcept Therapeutics Announces Phase 3 Study Evaluating CORLUX(R) for Psychotic Major Depression Misses Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Corcept Therapeutics Completes Enrollment in Third Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
Corcept Therapeutics Announces Negative Results From the Second of Three Phase 3 Studies Evaluating CORLUX(R) for Treating the Psychotic Features of Psychotic Major Depression
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
Corcept Therapeutics Completes Enrollment in Second Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
cortisol
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!